INFECTIOUS DISEASES:    HOME | SEARCH
case western reserve university

DIVISION OF INFECTIOUS DISEASES AND HIV MEDICINE

 

Robert Bonomo, MD

Dowd

Associate Professor of Medicine Director Cleveland VAMC GRECC

 

Phone: (216) 991-3800 ext 4399
Fax: (216) 241-3482
E-mail: robert.bonomo@med.va.gov

Education

BA-Hamilton College, 1976

MD-Case Western Reserve University School of Medicine, 1983

Residecny- University Hospitals of Cleveland, 1986

Infectious Diseases, University Hospitals of Cleveland,1994

Research

Among the major problems faced in medicine, resistance to antibiotics is regarded as a singular challenge. The primary focus of our laboratory is to understand the genetic and amino acid sequence determinants of the enzymes that inactivate ß-lactams, the ß-lactamases. Our current work is directed at solving three main problems:

(i) how ß-lactamase inhibitors inactivate -lactamases;
(ii) how ß-lactamases hydrolyze advanced generation cephalosporins; and
(iii) how mutations impact upon ß-lactamase expression. We are also interested in how penicillin interacts with penicillin resistant PBPs and the molecular epidemiology of extended spectrum ß-lactamases (ESBLs).

Lab Members: Andrea M. Hujer, Christopher R. Bethel

Collaborators: Dr. Marion S. Helfand, Dr. Curtis J. Donskey, Dr. Louis B. Rice, Dr. David L. Paterson, Dr. Focco van den Akker, Dr. Paul R. Carey, Dr. Vernon E. Anderson, Dr. James R. Knox, Dr. Malcolm Page, Dr. Lily Ng, Dr. John Buynak, Dr. Shu Chen, Dr. Michael Kinter, Dr. Anthony Fink, Dr. John Quinn.

 

 

NIH Biosketch

 

Selected References:

• Helfand MS, Hujer AM, and Sonnichsen FD, Bonomo RA. Unexpected advanced generation cephalosporinase activity of the M69F variant of SHV beta-lactamase. J Biol Chem. 2002 Dec 6; 277(49):47719-47723.

• Helfand MS, Bethel CR, Hujer AM, Hujer KM, Anderson VE, Bonomo RA. Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of Ser130. J Biol Chem. 2003 Dec 26; 278(52):52724-52729.

• Pagan-Rodriguez D, Zhou X, Simmons R, Bethel, CR, Hujer AM, Helfand MS, Jin Z, Guo B, Anderson VE, Ng LM, Bonomo RA. Tazobactam inactivation of SHV-1 and the inhibitor resistant Ser130Gly SHV-1 beta-lactamase: insights into the mechanism of inhibition. J Biol Chem. 2004 Feb 6 [Epub ahead of print].

• Hujer AM, Bethel CR, Bonomo RA. Antibody mapping of the linear epitopes of CMY-2 and SHV-1 beta-lactamases. In press. Antimicrob Agents Chemother. 2004